Exploring Neuregulin3: From physiology to pathology, a novel target for rational drug design
- 2 May 2025
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 238, 116964
Abstract
No abstract availableKeywords
Funding Information
- Amity University
This publication has 176 references indexed in Scilit:
- Transcriptional control of myelination and remyelinationGlia, 2019
- Targeting HER2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapyMolecular Oncology, 2018
- Developmental expression of Neuregulin‐3 in the rat central nervous systemJournal of Comparative Neurology, 2018
- Regulation of radial glial process growth by glutamate via mGluR5/TRPC3 and neuregulin/ErbB4Glia, 2017
- Does parental expressed emotion moderate genetic effects in ADHD? an exploration using a genome wide association scanAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- What is the genetic relationship between anxiety and depression?American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2008
- Culture conditions affect proliferative responsiveness of olfactory ensheathing glia to neuregulinsGlia, 2007
- Assaying Aspects of Attention and Impulse Control in Mice Using the 5‐Choice Serial Reaction Time TaskCurrent Protocols in Neuroscience, 2005
- A Suite of Novel Human Spermatozoal RNAsJournal of Andrology, 2005
- Proliferation and apoptosis in the developing human neocortexThe Anatomical Record, 2002